CEO Today - September 2022

THE CEO INTERVIEW www.ceotodaymagazine.com 23 There’s more to growth in the Raleigh Metro than simply demographics. The job market has exploded over the past five years – and it’s not slowing down anytime soon. Glassdoor named the Raleigh Metro area the #1 Best City for Jobs in 2020 with good reason. In fact, the Triangle saw 17% job growth in the last five years. Much of the strength of our local economy is routed in the diversity of our business ecosystem. The Raleigh Metro is home to four key industry clusters: Technology, Life Science, Advanced Manufacturing and CleanTech In 1965, IBM made the move to the Research Triangle Park, paving the way for the region to become an epicentre of technology. 50 years later, Apple announced that it would open a one million square foot research and development campus at RTP with 3,000 employees. The Raleigh Metro has been recognised as the second-fastest growing tech hub in the US. Our 4,000 tech companies employ more than 60,000 in software development, information security, and everything in between. Tech companies in the Raleigh Metro are innovators in interactive software/games, software development, open source, hardware manufacturing, defence technology, telecommunications, and nanotechnology. As a Top 5 largest life sciences hub in the country, the Raleigh Metro was recently ranked the #4 biopharma leader, the #6 life science leader and the #9 global life science hub by Business Facilities. Bolstered by 3 research universities—NC State University, UNC Chapel Hill, and Duke University—the Raleigh metro is a biotech and life sciences innovation leader and among the leading recipients of National Science Foundation and National Institutes of Health research funding. With more than 600 life sciences companies with operations here, employing 42,000+ people, the industry is growing at an exponential rate. “We continue our growth right here in North Carolina, after over two decades of being part of its biotechnology community,” said Martin Meeson, Chief Executive Officer of FUJIFILM Diosynth Biotechnologies. “Our recent $2 billionUSD investment is a confirmation of the central role of North Carolina’s Research Triangle region plays as leading biotechnology hub. This region will be key for us at FUJIFILM Diosynth Biotechnologies as we continue to support the biopharmaceutical industry in the development and manufacturing of the next generation of biotech medicines. North Carolina offers access to outstanding technical talent, great

RkJQdWJsaXNoZXIy Mjk3Mzkz